SCHEMBL1661025

SCHEMBL1661025

O=C(O)c1cc2ccccc2c(C(=O)O)c1-c1ccc2ccccc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
CYP1A2 P05177 2/20 0.54
CYP2C19 P33261 2/20 0.54
ALDH1A1 P00352 2/20 0.54
HPGD P15428 2/20 0.54
KDM4E B2RXH2 1/20 0.54
GLA P06280 1/20 0.54
HSD17B10 Q99714 1/20 0.54
ACMSD Q8TDX5 1/20 0.53
SOS1 Q07889 2/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
TSHR P16473 1/20 0.50
HIF1A Q16665 1/20 0.50
WDR5 P61964 1/20 0.47
FABP3 P05413 1/20 0.47
FABP4 P15090 1/20 0.47
FABP5 Q01469 1/20 0.47
ME2 P23368 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30421930 1.00 MEN1 (0.54) MEN1KMT2ACYP1A2CYP2C19ALDH1A1
SCHEMBL5888894 0.87 ACMSD (0.48) MEN1KMT2ACYP1A2CYP2C19ALDH1A1
SCHEMBL9938083 0.85 ACMSD (0.56) MEN1KMT2ACYP1A2CYP2C19ACMSD
SCHEMBL28652 0.80 MEN1 (0.70) MEN1KMT2ACYP1A2CYP2C19ALDH1A1
SCHEMBL30354048 0.80 MEN1 (0.70) MEN1KMT2ACYP1A2CYP2C19ALDH1A1
SCHEMBL31401681 0.80 MEN1 (0.70) MEN1KMT2ACYP1A2CYP2C19ALDH1A1
SCHEMBL30874069 0.80 WDR5 (0.71) MEN1KMT2ACYP1A2CYP2C19ALDH1A1
SCHEMBL2847759 0.79 MEN1 (0.58) MEN1KMT2ACYP1A2CYP2C19ALDH1A1
Potassium SCHEMBL31214964 0.79 MEN1 (0.68) MEN1KMT2ACYP1A2CYP2C19ALDH1A1
SCHEMBL10417205 0.79 MEN1 (0.68) MEN1KMT2ACYP1A2CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7125725-B2 Biaryl-type compounds, CD color fixing agent and method for determination of absolute configuration KANAZAWA UNIVERSITY (JP) 2006-10-24 US claimed
US-20040171662-A1 Biaryl-type compounds, CD color fixing agent and method for determination of absolute configuration KANAZAWA UNIVERSITY (JP) 2004-09-02 US claimed
US-20030088104-A1 Biaryl-type compounds, CD color fixing agent and method for determination of absolute configuration KANAZAWA UNIVERSITY (JP) 2003-05-08 US claimed
CN-116135866-A Bridged carboxylic acid-containing difunctional phosphine ligand, preparation method and application thereof 中山大学 2023-05-19 CN disclosed
EP-1958940-B1 CONDENSATION REACTION BY METAL CATALYST TAKASAGO PERFUMERY CO LTD (JP) 2013-06-26 EP disclosed
US-20110098479-A1 CONDENSATION REACTION BY METAL CATALYST MASHIMA KAZUSHI 2011-04-28 US disclosed
US-7888513-B2 Condensation reaction by metal catalyst TAKASAGO INTERNATIONAL CORPORATION (JP) 2011-02-15 US disclosed
US-20090198070-A1 Condensation Reaction by Metal Catalyst OSAKA UNIVERSITY (JP) 2009-08-06 US disclosed
EP-1958940-A1 CONDENSATION REACTION BY METAL CATALYST Takasago International Corporation (JP) 2008-08-20 EP disclosed
US-7125725-B2 Biaryl-type compounds, CD color fixing agent and method for determination of absolute configuration KANAZAWA UNIVERSITY (JP) 2006-10-24 US disclosed
US-20040171662-A1 Biaryl-type compounds, CD color fixing agent and method for determination of absolute configuration KANAZAWA UNIVERSITY (JP) 2004-09-02 US disclosed
US-6727098-B2 CIRCULAR DICHROISM KANAZAWA UNIVERSITY (JP) 2004-04-27 US disclosed
US-20030088104-A1 Biaryl-type compounds, CD color fixing agent and method for determination of absolute configuration KANAZAWA UNIVERSITY (JP) 2003-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098479-A1 CONDENSATION REACTION BY METAL CATALYST C9, CBR3, C1R MEN1 120/4885KMT2A 1055/4885CYP1A2 379/4885
US-20030088104-A1 Biaryl-type compounds, CD color fixing agent and method for determination of absolute configuration CDYL, DBF4, CDYL2 MEN1 3867/4885KMT2A 562/4885CYP1A2 429/4885
US-20040171662-A1 Biaryl-type compounds, CD color fixing agent and method for determination of absolute configuration CDYL, DBF4, CDYL2 MEN1 3867/4885KMT2A 562/4885CYP1A2 429/4885
US-20090198070-A1 Condensation Reaction by Metal Catalyst C9, CBR3, C1R MEN1 120/4885KMT2A 1055/4885CYP1A2 379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.